Skip to content

Organon logo

Main menu
      • Our focus
      • Products list
      • Patient support programs
      • Organon Pro for healthcare professionals
      • Safety data sheets
      • Product patents
      • Leadership team
      • Board of Directors
      • Corporate governance
    • Business development
    • Our culture
    • Our stories
    • Policies & positions
    • Environmental, social & governance
      • Our Suppliers
      • Supplier relationship management
    • Media
    • News
    • Investor relations overview
    • Events & presentations
    • SEC filings
    • Financial Information
    • Investor resources
  • Careers

Contact us

Visit Organon's Twitter Opens a new window Visit Organon's Facebook Opens a new window Visit Organon's LinkedIn Opens a new window Visit Organon's Instagram Opens a new window Visit Organon's YouTube Opens a new window

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:
Our focus > Products list

Organon’s products

The product websites presented here are intended for use in the United States, its territories and Puerto Rico only. Other countries may have different regulatory requirements and review practices that may require referencing different information. If you are a resident of a country other than the United States, please see our worldwide locations to find information about our offices around the globe.

Contact Organon Service Center

Report an adverse event

844-674-3200
Service_Center@Organon.com

You can call this number 24/7 for any product-related emergency.

Regular hours of operation: Monday – Friday 8:00 a.m. – 7:00 p.m. ET

For information about Organon’s products and services in the U.S., including the reporting of an Adverse Event or Product Quality Complaint with a specific Organon product, please call the Organon Service Center.

Healthcare professionals: visit Organon Pro

alphabetical search, letter A

alphabetical search, letter B

alphabetical search, letter C

alphabetical search, letter D

alphabetical search, letter E

alphabetical search, letter F

alphabetical search, letter G

alphabetical search, letter H

alphabetical search, letter I

alphabetical search, letter J

alphabetical search, letter K

alphabetical search, letter L

alphabetical search, letter M

alphabetical search, letter N

alphabetical search, letter O

alphabetical search, letter P

alphabetical search, letter Q

alphabetical search, letter R

alphabetical search, letter S

alphabetical search, letter T

alphabetical search, letter U

alphabetical search, letter V

alphabetical search, letter W

alphabetical search, letter X

alphabetical search, letter Y

alphabetical search, letter Z

A

ASMANEX® HFA (mometasone furoate) inhalation aerosol, for oral inhalation use
Product Website
Prescribing Information
Patient Product Information
ASMANEX® TWISTHALER® (mometasone furoate inhalation powder), for oral inhalation use
Product Website
Prescribing Information
Patient Product Information

B

There are no products for this section.

C

CELESTONE® SOLUSPAN® (betamethasone sodium phosphate and betamethasone acetate) Injectable Suspension, USP 30 mg/5 mL (6 mg/mL)
Prescribing Information
CLARINEX-D® 12 HOUR Extended Release Tablets (desloratadine/pseudoephedrine sulfate) for oral use
Prescribing Information
Patient Product Information
CLARINEX® (desloratadine) Tablets and Oral Solution for oral use
Prescribing Information
Patient Product Information
COZAAR® (losartan potassium) tablets, for oral use
Prescribing Information
Patient Product Information

D

DIPROLENE® (augmented betamethasone dipropionate) Ointment, for topical use
Prescribing Information
Patient Product Information
DULERA® (mometasone furoate and formoterol fumarate dihydrate) inhalation aerosol, for oral inhalation use
Product Website
Prescribing Information
Patient Product Information

E

There are no products for this section.

F

FOLLISTIM® AQ Cartridge (follitropin beta) injection, for subcutaneous use
Product Website
Prescribing Information
Patient Product Information and Instructions for Use
FOSAMAX® (alendronate sodium) tablets, for oral use
Prescribing Information
Medication Guide
FOSAMAX® PLUS D (alendronate sodium/cholecalciferol) tablets
Prescribing Information
Medication Guide

G

Ganirelix Acetate Injection
Prescribing Information

H

HADLIMA™ (adalimumab-bwwd) injection, for subcutaneous use
Prescribing Information
Medication Guide
Instructions for Use
Combined Prescribing Information, Medication Guide and Instructions for Use
HYZAAR® (losartan potassium and hydrochlorothiazide) tablets, for oral use
Prescribing Information
Patient Product Information

I

There are no products for this section.

J

Jada® System
Instructions for Use (blue seal valve and kit, green box)
Instructions for Use (white seal valve, white box)
Quick Reference Guide (blue seal valve and kit, green box)
Quick Reference Guide (white seal valve, white box)

K

There are no products for this section.

L

There are no products for this section.

M

MAXALT-MLT® (rizatriptan benzoate) orally disintegrating tablets
MAXALT® (rizatriptan benzoate) tablets, for oral use
Prescribing Information
Patient Product Information

N

NEXPLANON® (etonogestrel implant) Radiopaque Subdermal Use Only
Product Website
Prescribing Information
Patient Product Information
Combined Patient Product Information and Prescribing Information
NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring)
Product Website
Prescribing Information
Patient Product Information and Instructions for Use

O

ONTRUZANT® (trastuzumab-dttb) for injection, for intravenous use
Prescribing Information
Product Website

P

Pregnyl® (chorionic gonadotropin) for injection
Prescribing Information
PROPECIA® (finasteride) tablets for oral use
Prescribing Information
Patient Product Information
PROSCAR® (finasteride) Tablets
Prescribing Information
Patient Product Information

Q

There are no products for this section.

R

REMERON® (mirtazapine) tablets, for oral use
REMERONSolTab® (mirtazapine) orally disintegrating tablets
Prescribing Information
Medication Guide
RENFLEXIS™ (infliximab-abda) for injection, for intravenous use
Product Website
Prescribing Information
Medication Guide

S

SINEMET® (carbidopa and levodopa) Tablets
Prescribing Information
SINGULAIR® (montelukast sodium) chewable tablets, for oral use
SINGULAIR® (montelukast sodium) oral granules
SINGULAIR® (montelukast sodium) tablets, for oral use
Prescribing Information
Medication Guide
Instructions for Use

T

TOFIDENCE™ (tocilizumab-bavi) injection, for intravenous use
Prescribing Information
Medication Guide

U

There are no products for this section.

V

VTAMA® (tapinarof) Cream, 1%
Prescribing Information
Patient Product Information
Combined Patient Product Information and Prescribing Information
VYTORIN® (ezetimibe and simvastatin) tablets, for oral use
Prescribing Information
Patient Product Information

W

There are no products for this section.

X

XACIATO™ (clindamycin phosphate) vaginal gel
Product Website
Prescribing Information
Patient Product Information
Instructions for Use
Combination Prescribing Information, Patient Product Information and Instructions for Use

Y

There are no products for this section.

Z

ZETIA® (ezetimibe) tablets, for oral use
Prescribing Information
Patient Product Information
ZOCOR® (simvastatin) tablets, for oral use
Prescribing Information
Patient Product Information
Trademarks appearing on this website are owned, licensed to, promoted or distributed by Organon, its subsidiaries or affiliates, except as noted.

Connect with us on social

Linkedin icon Opens a new window Twitter icon Opens a new window Facebook icon Opens a new window Instagram icon Opens a new window YouTube icon Opens a new window
Organon logo

Company

  • About us
  • Our Leaders
  • Environmental, social & governance
  • Policies & positions

Resources

  • Patient resources
  • Investor relations
  • Media
  • Organon Pro for healthcare professionals

Contact us

  • Contact information
  • Global locations
  • Forward-Looking Statement
  • Cookie policy
  • Privacy Policy
  • Consumer Health Data Policy
  • Terms of Use
  • Sitemap
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies. This site is intended for residents of the United States.
Level Access website accessibility icon. Opens a new window TRUSTe Opens a new window

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

Any statements set forth on this website that are not historical facts are considered “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Organon’s management and are subject to significant risks and uncertainties. By their nature, forward-looking statements involve risks and uncertainties because they depend on circumstances that may or may not occur in the future. Although these statements are based on assumptions that we believe are reasonable when made, we caution you that forward-looking statements are not guarantees of future performance and you should not place undue reliance on them.

Organon undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s other filings with the Securities and Exchange Commission (SEC), including its registration statement on Form 10, available at the SEC’s Internet site (www.sec.gov Opens a new window).

Decline Accept